Aug. 22 at 12:52 AM
$IOVA Does anybody know or have an idea of the size of stock compensation component Corleen Roche, new IOVA CFO is set to receive? It is not yet submitted to sec.
She had a lower salary at
$CGON, a promising therapy for BCG-unresponsive NMIBC (planned for BLA filing later this year) but a significant equity component. Two questions pique my curiosity :
1) equity component in iova matches or far outweighs that of CGON or ;
2) she likes the approval chances of lung in IOVA vs that of CGON in nmibc ...
cast your views.
THX in advance